Beta‐lactam versus beta‐lactam‐aminoglycoside combination therapy in cancer patients with neutropenia

M Paul, Y Dickstein, A Schlesinger… - Cochrane Database …, 2013 - cochranelibrary.com
Background Continued controversy surrounds the optimal empirical treatment for febrile
neutropenia. New broad‐spectrum beta‐lactams have been introduced as single treatment …

The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients

J Klastersky, M Paesmans - Supportive care in cancer, 2013 - Springer
Abstract The Multinational Association for Supportive Care in Cancer risk index score
developed, through a multinational collaboration, was published in 2000 with the aim to …

Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical …

CR Flowers, J Seidenfeld, EJ Bow, C Karten… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To provide guidelines on antimicrobial prophylaxis for adult neutropenic oncology
outpatients and on selection and treatment as outpatients of those with fever and …

A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra‐amniotic infection in preterm labor with intact …

R Romero, J Miranda… - American journal of …, 2014 - Wiley Online Library
Problem The diagnosis of microbial invasion of the amniotic cavity (MIAC) has been
traditionally performed using traditional cultivation techniques, which require growth of …

Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial

FB Sime, MS Roberts, IS Tiong… - Journal of …, 2015 - academic.oup.com
Objectives The objectives of this study were to describe piperacillin exposure in febrile
neutropenia patients and determine whether therapeutic drug monitoring (TDM) can be …

Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs

K Thursky, S Lingaratnam, J Jayarajan… - BMJ open …, 2018 - bmjopenquality.bmj.com
Infection and sepsis are common problems in cancer management affecting up to 45% of
patients and are associated with significant morbidity, mortality and healthcare utilisation …

[18F] FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised …

A Douglas, K Thursky, T Spelman, J Szer… - The Lancet …, 2022 - thelancet.com
Background Management of neutropenic fever in high-risk haematology patients is
challenging; there are often few localising clinical features, and diagnostic tests have poor …

Septic shock in the immunocompromised cancer patient: a narrative review

JL Nates, F Pène, M Darmon, D Mokart, P Castro… - Critical Care, 2024 - Springer
Immunosuppressed patients, particularly those with cancer, represent a momentous and
increasing portion of the population, especially as cancer incidence rises with population …

[HTML][HTML] Manejo de los episodios de neutropenia febril en niños con cáncer. Consenso de la Sociedad Latinoamericana de Infectología Pediátrica 2021

ME Santolaya, V Contardo, JP Torres… - Revista chilena de …, 2021 - SciELO Chile
Resumen El Comité de Infecciones en el Niño Inmunocomprometido de la Sociedad
Latinoamericana de Infectología Pediátrica, entrega este documento de Consenso, llamado …

The emergency care of patients with cancer: setting the research agenda

J Brown, C Grudzen, DN Kyriacou, Z Obermeyer… - Annals of emergency …, 2016 - Elsevier
To identify research priorities and appropriate resources and to establish the infrastructure
required to address the emergency care of patients with cancer, the National Institutes of …